CTEPH Awareness Day

Key CTEPH Awareness Day activities
CTEPH updates: What you should know
CTEPH Awareness Day toolkit
Social media graphics
To share with others

Join the Pulmonary Hypertension Association in promoting CTEPH Awareness Day on Nov. 11. Observed on the second Wednesday of November, CTEPH Awareness Day was first launched by PHA in 2014 to raise awareness about chronic thromboembolic pulmonary hypertension, a form of pulmonary hypertension caused by old, organized blood clots in the lungs.

The observance highlights the importance of early diagnosis and treatment, because CTEPH can be overlooked or mistaken for other conditions. In most patients who have experienced a pulmonary embolism, blood thinners can help prevent additional blood clots. However, some people may still develop CTEPH even with treatment, and in some cases, the condition arises without a known history of blood clots. The good news is that effective treatments are available.

Use the resources below to raise awareness about CTEPH and learn more about its risks, symptoms, treatment options and what it’s like to live with the condition.

Key CTEPH Awareness Day activities

On Nov. 11, look out for PHA’s new Faces of PH series, which shares first-person stories from people living with pulmonary hypertension, including their path to diagnosis, treatment and life with the condition. For CTEPH Awareness Day, Tonya Gage shares her journey with CTEPH, including the challenges she faced before diagnosis, her treatment experience and how she continues to navigate life with the condition.
On Nov. 11, watch two newly released PHA Classroom videos:
- Who Should Be Considered for Balloon Pulmonary Angioplasty?
  Todd M. Bull, MD, director of the Pulmonary Vascular Disease Center at the University of Colorado School of Medicine, explains how care teams determine whether a person with chronic thromboembolic pulmonary hypertension may be a candidate for balloon pulmonary angioplasty. Learn about the specialists involved in the evaluation process, the potential benefits and risks of BPA and key considerations that guide treatment decisions.
- Medical Therapy for CTEPH
  Sonja Bartolome, MD, director of the Pulmonary Vascular Disease Program at the University of Texas Southwestern Medical Center, reviews medical treatment for chronic thromboembolic pulmonary hypertension, including approved medications and surgical and nonsurgical treatment options used to manage CTEPH.

CTEPH updates: What you should know

Join Sandeep Sahay, MD, MSc, ATSF, a pulmonologist at Baylor University Medical Center, for an overview of chronic thromboembolic pulmonary hypertension or CTEPH. Sahay will discuss advancements in CTEPH diagnosis and treatment, including surgical and medical options. He also will highlight lifestyle considerations, available support resources and how to work closely with healthcare providers to manage CTEPH.

CTEPH Updates: What You Should Know
Dr. Sandeep Sahay, MD, provides an overview of the latest advancements in CTEPH diagnosis and treatments. He shares tips on important lifestyle changes, how to find support resources, and the best ways to work with your health care team to get the care you need.